Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Med Life ; 2(4): 414-25, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-20108756

RESUMO

BACKGROUND: Rheumatoid arthritis (RA) is associated with loss of overall functionality of the locomotion system and it is connected with substantial economic losses. OBJECTIVE: To describe the clinical characteristics and healthcare resource utilization characteristics and to analyze the correlations in a cross-sectional sample of 206 patients in Romania. METHOD: RA cases have been enrolled from southern and western part of the country, covering a surface of 23 counties. RESULTS: Particularly in the literature data, Romanian RA patients become work disabled at 5.65 +/- 5.99 years old after the diagnosis. At cohort level, retirement in the first year after RA diagnosis is of 22.9%. From those, 13% were treated with biologic DMARDs; those on non-biologic DMARDs were 28.6%. In oral therapy group the most prescribed drug is lefunomide (61.2%). RA has an important impact on pain, function and utility, influenced by social factors. Patients' follow up is often based on hospitalization. CONCLUSION: Currently, when the clinician may choose for one certain therapy or another, the social influence is still overwhelming at all the evaluation levels in RA patients, as well as at economic impact.


Assuntos
Artrite Reumatoide/diagnóstico por imagem , Adalimumab , Adolescente , Adulto , Distribuição por Idade , Idoso , Anti-Inflamatórios não Esteroides/uso terapêutico , Anticorpos Monoclonais/uso terapêutico , Anticorpos Monoclonais Humanizados , Antirreumáticos/uso terapêutico , Artrite Reumatoide/complicações , Artrite Reumatoide/tratamento farmacológico , Pessoas com Deficiência , Etanercepte , Feminino , Humanos , Imunoglobulina G/uso terapêutico , Infliximab , Masculino , Pessoa de Meia-Idade , Radiografia , Receptores do Fator de Necrose Tumoral/uso terapêutico , Romênia/epidemiologia , Índice de Gravidade de Doença , Adulto Jovem
2.
Pneumologia ; 55(3): 128-9, 2006.
Artigo em Romano | MEDLINE | ID: mdl-17144483

RESUMO

Recovery in COPD includes, as a mandatory stage, the patient's nutritional evaluation, followed by the necessary therapeutic indications. Weight loss has negative effects on the skeletal muscle mass, therefore a kinetic program, without being supported by the appropriate therapy, has a much lower effect. Recent studies show a beneficial effect generated by a high intake of vitamin C, vitamin E, omega-3 fat acid and nutritional supplements. The hormonal therapy is given a controversial place, but it requires extensive studies.


Assuntos
Doença Pulmonar Obstrutiva Crônica/dietoterapia , Doença Pulmonar Obstrutiva Crônica/reabilitação , Gorduras Insaturadas na Dieta/administração & dosagem , Ácidos Graxos Ômega-3/administração & dosagem , Humanos , Minerais/administração & dosagem , Apoio Nutricional , Guias de Prática Clínica como Assunto , Qualidade de Vida , Vitaminas/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...